Human papillomavirus vaccination coverage among females and males, National Health and Nutrition Examination Survey, United States, 2007–2016 ()

by Lewis, Rayleen M., Markowitz, Lauri E.
Published in Vaccine (2018)

The Cost-effectiveness of Human Papillomavirus Vaccine Catch-up Programs for Women

by Chesson, Harrell W., Markowitz, Lauri E.
Published in J Infect Dis (2014)

Uptake of Human Papillomavirus Vaccine Among Adolescent Males and Females: Immunization Information System Sentinel Sites, 2009–2012

by Cullen, Karen A., Stokley, Shannon, Markowitz, Lauri E.
Published in Acad Pediatr (2014)

Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States

by Gee, Julianne, Weinbaum, Cindy, Sukumaran, Lakshmi, Markowitz, Lauri E.
Published in Hum Vaccin Immunother (2016)

Timing of HPV vaccine intervals among United States teens with consideration to the current ACIP schedule and the WHO 2-dose schedule

by Cloessner, Emily A., Stokley, Shannon, Yankey, David, Markowitz, Lauri E.
Published in Hum Vaccin Immunother (2015)

Human Papillomavirus Vaccination and Age at First Sexual Activity, National Health and Nutrition Examination Survey

by Petrosky, Emiko Y., Liu, Gui, Hariri, Susan, Markowitz, Lauri E.
Published in Clin Pediatr (Phila) (2016)

Cost-effectiveness of Human Papillomavirus Vaccination in the United States

by Chesson, Harrell W., Ekwueme, Donatus U., Saraiya, Mona, Markowitz, Lauri E.
Published 2008

HPV vaccine coverage among men who have sex with men – National HIV Behavioral Surveillance System, United States, 2011

by Meites, Elissa, Markowitz, Lauri E., Paz-Bailey, Gabriela, Oster, Alexandra M.
Published in Vaccine (2014)

Health Care Use and Opportunities for Human Papillomavirus Vaccination Among Young Men Who Have Sex With Men

by Meites, Elissa, Krishna, Nevin K., Markowitz, Lauri E., Oster, Alexandra M.
Published in Sex Transm Dis (2013)

Impact and Cost-effectiveness of 3 Doses of 9-Valent Human Papillomavirus (HPV) Vaccine Among US Females Previously Vaccinated With 4-Valent HPV Vaccine

by Chesson, Harrell W., Laprise, Jean-François, Brisson, Marc, Markowitz, Lauri E.
Published in J Infect Dis (2016)

Increasing Human Papillomavirus Vaccination at the Recommended Age

by Lin, Xia, Shrader, Lauren, Rodgers, Loren, Stokley, Shannon, Markowitz, Lauri E.
Published in Vaccine (2018)

The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States

by Chesson, Harrell W., Dunne, Eileen F., Hariri, Susan, Markowitz, Lauri E.
Published in Sex Transm Dis (2014)

Population Impact of HPV Vaccines: Summary of Early Evidence

by Hariri, Susan, Markowitz, Lauri E., Dunne, Eileen F., Unger, Elizabeth R.
Published in J Adolesc Health (2013)

Seroprevalence of Herpes Simplex Virus Types 1 and 2 Among Pregnant Women and Sexually Active, Nonpregnant Women in the United States

by Patton, Monica E., Bernstein, Kyle, Liu, Gui, Zaidi, Akbar, Markowitz, Lauri E.
Published in Clin Infect Dis (2018)

Human Papillomavirus Vaccination Coverage Among Adolescent Girls, 2007–2012, and Postlicensure Vaccine Safety Monitoring, 2006–2013 — United States

by Stokley, Shannon, Curtis, C. Robinette, Jeyarajah, Jenny, Harrington, Theresa, Gee, Julianne, Markowitz, Lauri
Published in MMWR Morb Mortal Wkly Rep (2013)

The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model

by Chesson, Harrell W., Markowitz, Lauri E., Hariri, Susan, Ekwueme, Donatus U., Saraiya, Mona
Published in Hum Vaccin Immunother (2016)

Comparison of 2-Dose and 3-Dose 9-Valent Human Papillomavirus Vaccine Schedules in the United States: A Cost-effectiveness Analysis

by Laprise, Jean-François, Markowitz, Lauri E., Chesson, Harrell W., Drolet, Mélanie, Brisson, Marc
Published in J Infect Dis (2016)

Human Papillomavirus Vaccination Coverage Using Two-dose or Three-dose Schedule Criteria

by Lin, Xia, Rodgers, Loren, Zhu, Liping, Stokley, Shannon, Meites, Elissa, Markowitz, Lauri E.
Published in Vaccine (2017)

2463. Post-licensure Surveillance of 9-Valent Human Papillomavirus Vaccine (9vHPV) in the Vaccine Adverse Event Reporting System (VAERS), United States, 2014–2017

by Arana, Jorge, Su, John, Lewis, Paige, Cano, Maria, Markowitz, Lauri E, Shimabukuro, Tom
Published in Open Forum Infect Dis (2018)

Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States ☆

by Chesson, Harrell W., Meites, Elissa, Ekwueme, Donatus U., Saraiya, Mona, Markowitz, Lauri E.
Published in Vaccine (2018)